|
Volumn 73, Issue 2, 1994, Pages 141-146
|
Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis
a a a a a a a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
AZELASTINE;
CLEMASTINE FUMARATE;
PLACEBO;
ADOLESCENT;
ADULT;
AGED;
ALLERGIC RHINITIS;
ARTICLE;
CHILD;
CHRONIC RHINITIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
EPISTAXIS;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
MYALGIA;
NOSE CONGESTION;
PHARYNGITIS;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHINORRHEA;
SIDE EFFECT;
SINGLE BLIND PROCEDURE;
SOMNOLENCE;
SYMPTOMATOLOGY;
TASTE DISORDER;
UPPER RESPIRATORY TRACT INFECTION;
WEIGHT GAIN;
XEROSTOMIA;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
AGED;
BRONCHODILATOR AGENTS;
CHILD;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PHTHALAZINES;
RHINITIS, ALLERGIC, PERENNIAL;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
|
EID: 0028038180
PISSN: 00034738
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (21)
|
References (0)
|